BAA ANNOUNCEMENT: REGIONAL BIOCONTAINMENT LABORATORIES (RBL) AND NATIONAL 
BIOCONTAINMENT LABORATORIES (NBL) – BAA-NIH-NIAID-NCRR-DMID-03-36

RELEASE DATE:  October 7, 2002

NOTICE: NOT-AI-02-059

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)
National Center for Research Resources (NCRR)
 (http://www.ncrr.nih.gov/)

Receipt Date:  February 10, 2003

DESCRIPTION

The Department of Health and Human Services (DHHS), National Institutes of 
Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) 
and the National Center for Research Resources (NCRR), are collaborating on 
the subject Broad Agency Announcement.  The NIAID and NCRR encourages the 
submission of grant applications and/or contract proposals for the 
establishment of Regional and National Biocontainment Laboratories, 
respectively, in order to further the research capabilities of the Division 
of Microbiology and Infectious Diseases (DMID), NIAID, to conduct research on 
Category A, B, and C priority pathogens that are considered to be of 
significant research importance. The list of pathogens is provided at the 
following website: (http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm).  
Only domestic (U.S.), non-Federal, public or private 
non-profit organizations that support biomedical research are eligible to apply.  
Awards under this program are contingent on availability of appropriated funds 
and NIAID appropriations authority provided at the discretion of Congress.  In 
February of 2002, the NIAID developed a strategic plan for biodefense research 
in consultation with a Blue Ribbon Panel to accomplish short- and long-term 
goals aimed at protection of the United States and the world population against 
attacks by these agents.  The NIAID strategic plan emphasizes both basic 
research and the application of the basic research to the development of 
products such as diagnostics, therapeutics, and vaccines.  The Biocontainment 
Laboratories being solicited through this Broad Agency Announcement (BAA) will 
be an integral part of the biodefense research agenda of the NIAID.  This BAA 
will consist of two parts:  Part A - Regional Biocontainment Laboratories (RBLs) 
to be awarded as grants and Part B – National Biocontainment Laboratories 
(NBLs) to be awarded as contracts.  PART A – RBLs:  The overall planned 
objective of the RBL construction program is to provide funding to design, 
build, renovate, certify and install fixed equipment into state-of-the-art 
BSL-3 biocontainment laboratories and the necessary associated BSL-2 labs, 
animal facilities, and research support space.   RBLs will be required to 
preferentially support the research activities of NIAID Regional Centers of 
Excellence for Biodefense and Emerging Infectious Diseases Research (RCE), as 
well as other NIAID funded biodefense and emerging infectious diseases 
research.  RBLs will be part of the NIAID RCE Biodefense Network and will 
serve as a regional resource for research institutions in the region.  In 
addition, RBLs will be required to be available and prepared to assist 
national, state, and local public health efforts in the event of a 
bioterrorism emergency.  PART B – NBLs:  The overall objective of the NBL 
construction program is to provide funding to design, build, and certify 
comprehensive, state-of-the-art BSL-4 biocontainment laboratories and the 
necessary associated BSL-3 labs, BSL-2 labs, animal facilities, and research 
support space. NBLs will serve as a national resource for efforts in 
conducting clinical and laboratory (in vitro and in vivo) research and 
testing on hazardous biological agents in support of the NIAID's Biodefense 
Agenda.  NBLs will be required to preferentially support the research 
activities of NIAID Regional Centers of Excellence for Biodefense and 
Emerging Infectious Diseases Research (RCE), as well as other NIAID funded 
biodefense research.  NBLs will be part of the NIAID RCE Biodefense Network 
and will serve as a national resource for research.  In addition, NBLs must 
be available and prepared to assist national, state, and local public health 
efforts in the event of a bioterrorism emergency.

BAA-NIH-NIAID-NCRR-DMID-03-36 will be available electronically on or about 
October 15, 2002, and may be accessed through the NIAID Contract Management 
Branch (CMB) home page at   http://www.niaid.nih.gov/cgi-shl/cmb/rfps.cfm and 
will be posted on FedBizOpps at  http://www.fedbizopps.gov/.  Any responsible 
offeror may submit a proposal that will be considered by the Government.  This 
announcement does not commit the Government to make an award.  No collect 
calls will be accepted.  No facsimile transmission will be accepted.

Contracting Office Address:

For Contracts:

National Institutes of Health
National Institutes of Allergy and Infectious Diseases
Contract Management Branch 
6700-B Rockledge Drive
Room 2230, MSC 7612 
Bethesda, MD, 20892-7612

Original Point of Contact:

For Contracts (NBLs): Barbara Shadrick, Senior Contracting Officer, Phone 
301-496-7288, Fax 301-480-5253, Email bs92y@nih.gov 

For Grants (RBLs): Mary Kirker, Grants Manager Officer, Phone 301-402-6400, 
Fax 301-480-3780, Email mk35h@nih.gov

Secondary Point of Contact

For Contracts (NBLs):  Kristen Mistichelli, Contracting Officer, Phone 301-
496-0384, Fax 301-480-5253, Email kmistichelli@niaid.nih.gov 

For Grants (RBLs): Linda Shaw, Grants Management Specialist, Phone 301-402-
6611, Fax 301-480-3780, Email ls15k@nih.gov.


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.